Prenetics Global Limited Class A Ordinary Share (PRE) is a publicly traded Healthcare sector company. As of May 20, 2026, PRE trades at $15.25 with a market cap of $247.19M and a P/E ratio of 0.00. PRE moved +4.28% today. Year to date, PRE is -7.38%; over the trailing twelve months it is +110.89%. Its 52-week range spans $3.09 to $23.63. Analyst consensus is buy with an average price target of $32.50. Rallies surfaces PRE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
PRE financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PRE recently traded at $15.25. Market cap is $247.19M. P/E ratio is 0.00. Revenue is $5.39B.
| Metric | Value |
|---|---|
| Price | $15.25 |
| Market Cap | $247.19M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.70% |
| 52-Week High | $23.63 |
| 52-Week Low | $3.09 |
| Volume | 64.78K |
| Avg Volume | 0 |
| Revenue (TTM) | $5.39B |
| Net Income | $74.63M |
| Gross Margin | 14.89% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2015 | $5.43B | $107.15M | $1.00 |
| 2014 | $6.48B | $1.07B | $19.96 |
| 2013 | $5.54B | $673.44M | $10.78 |
| 2012 | $5.56B | $1.13B | $17.05 |
2 analysts cover PRE: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $32.50.